Literature DB >> 31828744

Decompression illness (DCI) in Finland 1999-2018: Special emphasis on technical diving.

Richard V Lundell1,2,3, Olli Arola4, Jari Suvilehto5, Juha Kuokkanen5, Mika Valtonen4, Anne K Räisänen-Sokolowski2,5,6.   

Abstract

INTRODUCTION: This is the first published study on decompression illness (DCI) and its treatment in Finland. Diving conditions are demanding, as even in the summer the water temperature below 20 meters' sea/fresh water (msw/mfw) is 4-10°C. Technical diving has become more popular over the years, so the emphasis of this study was to describe DCI in technical divers and compare it with non-technical recreational divers.
METHODS: This study includes by estimation over 95% of all hyperbaric oxygen-treated DCI patients during the years 1999-2018 (n = 571). The cases were divided into technical divers (n = 200) and non-technical divers (n = 371). We focused on the differences between these two groups. Technical diving was defined as the usage of mixed breathing gases, closed circuit rebreather diving or planned decompression diving.
RESULTS: The mean annual number of treated DCI cases in Finland was 29 (range 16-38). The number of divers treated possibly indicate a shift towards technical diving. Technical dives were deeper and longer and were mainly performed in cold water or an overhead environment. Technical divers were more likely to utilize first aid 100% oxygen (FAO2) and sought medical attention earlier than non-technical divers. Symptom profiles were similar in both groups. Recompression was performed using USN Treatment Table Six in the majority of the cases and resulted in good final outcome. Eighty two percent were asymptomatic on completion of all recompression treatment(s).
CONCLUSION: This 20-year observational study indicates a shift towards technical diving, and hence a more demanding and challenging style of diving among Finnish divers, with a surprisingly constant number of DCI cases over the years. There is still need for improvement in divers' education in use of FAO2 for DCI symptoms. Fortunately, the outcome after recompression therapy is generally successful. Copyright: This article is the copyright of the authors who grant Diving and Hyperbaric Medicine a non-exclusive licence to publish the article in electronic and other forms.

Entities:  

Keywords:  Arctic diving; Decompression sickness; Diving; Epidemiology; First aid oxygen; Hyperbaric oxygen treatment

Mesh:

Year:  2019        PMID: 31828744      PMCID: PMC7039777          DOI: 10.28920/dhm49.4.259-265

Source DB:  PubMed          Journal:  Diving Hyperb Med        ISSN: 1833-3516            Impact factor:   0.887


  21 in total

1.  Analyses of treatment for divers with actual or suspected decompression illness.

Authors:  Martin Dj Sayer; John As Ross; Colin M Wilson
Journal:  Diving Hyperb Med       Date:  2009-09       Impact factor: 0.887

2.  Prognostic factors of spinal cord decompression sickness in recreational diving: retrospective and multicentric analysis of 279 cases.

Authors:  Jean-Eric Blatteau; E Gempp; O Simon; M Coulange; B Delafosse; V Souday; G Cochard; J Arvieux; A Henckes; P Lafere; P Germonpre; J-M Lapoussiere; M Hugon; P Constantin; A Barthelemy
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

3.  Proposing short-term observation units for the management of decompression illness.

Authors:  R Tempel; H W Severance
Journal:  Undersea Hyperb Med       Date:  2006 Mar-Apr       Impact factor: 0.698

4.  First aid normobaric oxygen for the treatment of recreational diving injuries.

Authors:  J M Longphre; P J Denoble; R E Moon; R D Vann; J J Freiberger
Journal:  Undersea Hyperb Med       Date:  2007 Jan-Feb       Impact factor: 0.698

5.  Effects of a standard hyperbaric oxygen treatment protocol on pulmonary function.

Authors:  E Thorsen; L Aanderud; T B Aasen
Journal:  Eur Respir J       Date:  1998-12       Impact factor: 16.671

Review 6.  Decompression illness.

Authors:  Richard D Vann; Frank K Butler; Simon J Mitchell; Richard E Moon
Journal:  Lancet       Date:  2011-01-08       Impact factor: 79.321

7.  Effects of ambient temperature on nitrogen uptake and elimination in humans.

Authors:  David R Pendergast; Curtis J Senf; Michael C Fletcher; Claes E G Lundgren
Journal:  Undersea Hyperb Med       Date:  2015 Jan-Feb       Impact factor: 0.698

8.  DCS or DCI? The difference and why it matters.

Authors:  Simon J Mitchell
Journal:  Diving Hyperb Med       Date:  2019-09-30       Impact factor: 0.887

9.  Delayed recompression for decompression sickness: retrospective analysis.

Authors:  Amir Hadanny; Gregori Fishlev; Yair Bechor; Jacob Bergan; Mony Friedman; Amit Maliar; Shai Efrati
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

10.  Decompression illness: clinical aspects of 5278 consecutive cases treated in a single hyperbaric unit.

Authors:  Wenbing Xu; Wenwu Liu; Guoyang Huang; Zijiao Zou; Zhiyu Cai; Weigang Xu
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

View more
  4 in total

1.  Decompression illness in Finnish technical divers: a follow-up study on incidence and self-treatment.

Authors:  Laura J Tuominen; Sofia Sokolowski; Richard V Lundell; Anne K Räisänen-Sokolowski
Journal:  Diving Hyperb Med       Date:  2022-06-30       Impact factor: 1.228

2.  Diving Responses in Experienced Rebreather Divers: Short-Term Heart Rate Variability in Cold Water Diving.

Authors:  Richard V Lundell; Laura Tuominen; Tommi Ojanen; Kai Parkkola; Anne Räisänen-Sokolowski
Journal:  Front Physiol       Date:  2021-04-07       Impact factor: 4.566

3.  Physiology of repeated mixed gas 100-m wreck dives using a closed-circuit rebreather: a field bubble study.

Authors:  Costantino Balestra; François Guerrero; Pierre Lafère; Sigrid Theunissen; Peter Germonpré
Journal:  Eur J Appl Physiol       Date:  2021-11-28       Impact factor: 3.078

4.  Latent Class Analysis of Decompression Sickness Symptoms of Women Divers.

Authors:  Da-Jung Kim; Jeong-Won Han
Journal:  Healthcare (Basel)       Date:  2022-07-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.